IMVT
Immunovant, Inc. · Healthcare
Chief Medical Officer Michael Geffner sold $94K of Immunovant, Inc.
Sold$94,171
$29.53Price
3,189Shares
−2%Stake
What IMVT did after the filing
- The stock from Fri, Oct 25 close, $30.22
- −5.0%
- S&P 500, same days
- +4.4%
Measured over 30 trading days, to the Dec 9 close.
Traded Wed, Oct 23. Filed Fri, Oct 25, 12:23 PM ET, during the session. Returns use the Oct 25 close and the Dec 9 close. Not investment advice.